Successfully Sharing Our Stories of Science

Illustration: A. Canamucio The ethos of our science was articulated by Leonardo da Vinci 500 years ago: "A bird is an instrument working according to mathematical law." This replaced the medieval mystical view that it was the soul of the bird that embodied the nature of flight. How beautifully the work honored recently by the Lasker Awards mirrors that transition.1 The work of Peter C. Nowell, Janet D. Rowley, and Alfred G. Knudson replaced the mystical soul of the cancer cell with the instrum

Written byRichard Klausner
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Illustration: A. Canamucio
The ethos of our science was articulated by Leonardo da Vinci 500 years ago: "A bird is an instrument working according to mathematical law." This replaced the medieval mystical view that it was the soul of the bird that embodied the nature of flight.

How beautifully the work honored recently by the Lasker Awards mirrors that transition.1 The work of Peter C. Nowell, Janet D. Rowley, and Alfred G. Knudson replaced the mystical soul of the cancer cell with the instrument of physical changes in DNA--a molecule whose structure we know. The many disparate observed causes of cancer--chemicals, viruses, radiation, heredity--causes unconnected by mechanism to the disease--are all comprehensible through the crucible of actual alterations in the DNA. A phenomenon turned into an instrument, obeying rules and becoming not just known but comprehensible.

The work of Paul Nurse, Lee Hartwell, and Yoshio Masui told us that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies